FAQ

WJD 008

Known as: WJD-008, WJD008 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2018
0120032018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Simultaneous determination of AM80 (tamibarotene) and WJD-A-1 in rat plasma by ultra high-performance liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study.
A compound (WJD-A-1) was previously reported as a candidate prodrug of Am80 (tamibarotene), which was approved in Japan in 2005… (More)
Is this relevant?
2013
2013
A pharmacological model reveals biased dependency on PI3K isoforms for tumor cell growth
Aim:To identify the contribution of individual isoform (α, β, γ, δ) of class I PI3Ks to tumor cell growth for proper use of PI3K… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2010
2010
WJD008, a dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin inhibitor, prevents PI3K signaling and inhibits the proliferation of transformed cells with oncogenic PI3K mutant.
The phosphatidylinositol-3-kinase (PI3K)-protein kinase B (Akt)-mammalian target of rapamycin (mTOR) signaling pathway is often… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
Review
2003
Review
2003
Giant choroid plexus papilloma of the third ventricle.
A 19-year old female with blue rubber bleb nevus syndrome. Endoscopic laser photocoagulation and surgical resection of… (More)
  • figure 1-3
  • figure 4
  • figure 5
  • figure 7
  • figure 6
Is this relevant?